-
St. Jude trial identifies a medulloblastoma subset that requires less aggressive therapy
05/17/2018
For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
-
‘Lone wolf’ protein offers new pathway to cancer treatments
05/16/2018
The protein called BOK offers another target for drugs to selectively trigger apoptosis.
-
St. Jude named the World Health Organization’s first Collaborating Centre for Childhood Cancer
05/16/2018
St. Jude is partnering with WHO to develop strategies that strengthen the global resources, organization and planning needed to identify and treat pediatric cancer.
-
Genetic counseling and testing proposed for patients with the brain tumor medulloblastoma
05/09/2018
Researchers created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible.
-
Research pinpoints viral mutation that would trigger resistance to new anti-influenza drugs
04/24/2018
Using combination therapy for flu, a new class of drug offers potential for multi-drug therapy and possibly improved influenza-fighting drugs.
-
Discovery adds to evidence that some children are predisposed to develop leukemia
04/19/2018
A family’s history of childhood leukemia leads to the discovery of a fourth gene (IKZF1) that predisposes carriers to pediatric acute lymphoblastic leukemia.
-
St. Jude Cloud, largest public repository of pediatric cancer genomics data, launches for researchers worldwide
04/12/2018
St. Jude to offer next-generation sequencing data and analysis tools to accelerate research and cures for life-threatening pediatric diseases.
-
St. Jude at AACR 2018
04/12/2018
Explore research and resources by St. Jude at the annual meeting of the American Association for Cancer Research (AACR) in Chicago.
-
Neurocognitive risk may begin before treatment for young leukemia patients
03/29/2018
What explains cognitive problems in childhood leukemia survivors treated with chemotherapy alone? The answer may be a surprise.
-
Researchers discover a ‘security chief’ that helps sound the alarm against infections
03/22/2018
Read about the molecule (IRF8) that is essential for launching an optimal immune response to Salmonella, Pseudomonas and related bacteria.
-
Immune system 'double agent' could be new ally in cancer fight
03/15/2018
The immune system is full of surprises. Here is one about a kinase that plays an unexpected role in regulating inflammation and cell death in myeloid cells.
-
Study identifies potential drug for treatment of debilitating inherited neurological disease
03/14/2018
St. Jude scientists have demonstrated in model studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs.
-
St. Jude teams up with NBA Cares to combat childhood cancer during Hoops for St. Jude™ Week
03/08/2018
NBA players, coaches, broadcasters and fans rally behind St. Jude and NBA Cares during Hoops for St. Jude week.
-
Many adolescent and young adult cancer survivors have more social connections than peers
03/08/2018
Researchers have developed a new method to measure social networks of adolescent and young adult cancer survivors. What they found might surprise you.
-
Researchers home in on possible drug to prevent hearing loss
03/07/2018
Millions of people have lost their hearing due to noise, chemotherapy, age or other insults. Read about efforts to help prevent such losses in the future.
-
‘Rheostat’ identified that helps regulate cell death versus survival decisions
03/05/2018
A little disorder is helpful sometimes. Read how an intrinsically disordered region of the protein Bcl-xL helps cells integrate messages regarding apoptosis.
-
Patrick Warburton Celebrity Golf Tournament raises a record $2.5 million for kids of St. Jude
03/05/2018
The eighth annual Patrick Warburton Celebrity Golf Tournament raised a record $2.5 million for St. Jude.
-
ALSAC/ St. Jude and LeMoyne-Owen College open call center to give students opportunity to learn new skills, take part in St. Jude mission
03/02/2018
St. Jude has opened the LeMoyne-Owen College University Engagement Call Center, a St. Jude donor engagement facility where student interns will perform outgoing calls to thank donors for their support.
-
Keith Urban, Ne-Yo, Hanson, Anthony Hamilton and more join #ThisShirtSavesLives to support St. Jude and help end childhood cancer
03/01/2018
Celebrities continue to join the popular #ThisShirtSavesLives campaign to help raise funds and awareness for the lifesaving mission of St. Jude Children’s Research Hospital.
-
St. Jude honors Bernal Smith II at St. Jude Spirit of the Dream event hosted by actress Elise Neal
02/28/2018
Guests attended the St. Jude Spirit of the Dream to celebrate the achievements and contributions that African Americans have made to the St. Jude legacy.
-
Genomic analysis underscores need for precision therapies that target pediatric cancer
02/28/2018
The most comprehensive look ever across the genomic landscape of childhood cancer reinforces the need for precision medicine to treat pediatric cancer.
-
Effective pediatric cancer treatment is possible in the midst of a refugee crisis
02/28/2018
War in Syria sent refugees flooding into Lebanon. Read about the life-saving effort to deliver effective treatment to refugee children with cancer.
-
St. Jude Children's Research Hospital, Microsoft and DNAnexus join forces to fuel scientific discovery
02/28/2018
Partnership established to analyze and store pediatric cancer genomics data, support data sharing and encourage greater collaboration among scientists worldwide.
-
Study reveals key inner control mechanism of cell's 'smart glue'
02/26/2018
St. Jude researchers reveal importance of nucleophosmin during liquid-liquid phase separation and the proteins’ role in the structure of the nucleolus.
-
St. Jude to develop $412 million research center to advance discovery
02/19/2018
The advanced research center builds on the St. Jude legacy of innovations for understanding and treating childhood cancer and other life-threatening diseases.
-
St. Jude Children's Research Hospital named to Fortune magazine’s ‘100 Best Companies to Work For’ for eighth consecutive year
02/15/2018
St. Jude recognized for having exceptional workplace culture based upon employee surveys and an in-depth questionnaire.
-
St. Jude and Lyft partner to allow riders to round up and donate to help end childhood cancer
01/30/2018
Brett Eldredge invited St. Jude patients to be his personal guests at an upcoming concert to help launch a new partnership between St. Jude and Lyft.
-
St. Jude and Cumulus Media raise more than $1 million
01/26/2018
Cumulus Media expanded its longstanding support of St. Jude, raising more than $1 million and facilitating the new, first-time foray into the classic rock radio station format for St. Jude.
-
‘Hijacker’ drives cancer in some patients with high-risk neuroblastoma
01/23/2018
Researchers used a new method to model the cancer genome in 3-D and show how the c-MYC oncogene drives high-risk neuroblastoma in some patients.
-
St. Jude collaborates with GenZ YouTube star Sebastian Villalobos to help end childhood cancer
01/17/2018
St. Jude has teamed up with digital influencer Sebastian Villalobos to spread it's mission to new audiences across the digital landscape.
